NCT04405076 Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older Status COMPLETED Phase PHASE2
NCT04392739 Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG Status COMPLETED Phase PHASE4
NCT04386616 A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04380207 P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV Status COMPLETED Phase PHASE1
NCT04320485 Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI) Status COMPLETED Phase N/A
NCT04090424 Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns Status ACTIVE_NOT_RECRUITING Phase NA
NCT04067011 Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study Status COMPLETED Phase PHASE2
NCT04064905 Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults Status COMPLETED Phase PHASE1
NCT03972111 A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox Status WITHDRAWN Phase N/A
NCT03776903 Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA Status COMPLETED Phase N/A
NCT03626701 RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years Status TERMINATED Phase NA
NCT03624192 RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years Status TERMINATED Phase NA
NCT03568942 Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) Status COMPLETED Phase PHASE2